Authors
Peter J Dickinson, Michael Bannasch, Sara M Thomasy, Vishal D Murthy, Karen M Vernau, Molly Liepnieks, Elizabeth Montgomery, Kelly E Knickelbein, Brian Murphy, Niels C Pedersen
Publication date
2020/7
Journal
Journal of veterinary internal medicine
Volume
34
Issue
4
Pages
1587-1593
Publisher
John Wiley & Sons, Inc.
Description
Feline infectious peritonitis (FIP) is caused by a mutant biotype of the feline enteric coronavirus. The resulting FIP virus (FIPV) commonly causes central nervous system (CNS) and ocular pathology in cases of noneffusive disease. Over 95% of cats with FIP will succumb to disease in days to months after diagnosis despite a variety of historically used treatments. Recently developed antiviral drugs have shown promise in treatment of nonneurological FIP, but data from neurological FIP cases are limited. Four cases of naturally occurring FIP with CNS involvement were treated with the antiviral nucleoside analogue GS‐441524 (5‐10 mg/kg) for at least 12 weeks. Cats were monitored serially with physical, neurologic, and ophthalmic examinations. One cat had serial magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) analysis (including feline coronavirus [FCoV]) titers and FCoV reverse transcriptase [RT …
Total citations
20202021202220232024112928218